Evaluation of complementary therapy with Capparis spinosa on MS patients
Phase 2
Recruiting
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20180103038199N15
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients with multiple sclerosis (MS)
Having an EDSS score between zero and 5.5
Having stable and regular drug treatment in the last 4 weeks
Consent not to use complementary medicines from 7 days before the start of the intervention until the end of the intervention
Age between 18 and 60 years
Consent to admission to the study
Exclusion Criteria
History of alcohol or drug addiction
History of pregnancy or breastfeeding in the last 12 months
Kidney and liver dysfunction
Treatment with steroids during the last 2 months before the start of the study
Having a neurological disease in addition to MS
Having cardiovascular or infectious disease
Having a history of severe respiratory or skin sensitivity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in disease symptoms based on EDSS. Timepoint: At the beginning of the study and after 3 months of treatment. Method of measurement: Checklist.
- Secondary Outcome Measures
Name Time Method Changes in Interleukin-4 levels. Timepoint: At the beginning of the study and after 3 months of treatment. Method of measurement: Laboratory kit.;Changes in Interferon-gamma levels. Timepoint: At the beginning of the study and after 3 months of treatment. Method of measurement: Laboratory kit.